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Conclusions: The obtained results have shown the possible relation 
between the GSTT1 genotype and the level of chromosome aberrations 
in somatic cells of lung cancer patients. 
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Background: The clinical application of monoclonal antibodies has 
been well established for the treatment of various human cancers. 
However, there were a few reports which showed the effectiveness of 
antibody therapy against lung cancer. In the present study, we report a 
novel cell surface antigen which was identiﬁed by SEREX method by 
using the antibody (Ab) derived from tumor-inﬁltrating B lymphocytes 
(TIB).
Methods: A904L, a lung large cell carcinoma cell line, was established 
from patient A904. The surgically resected lung cancer specimens of 
the patient was xenotransplanted into SCID mice. SCID mice engrafted 
with the lung cancer were bled by retro-orbital venipuncture every 2 
weeks and the amount of human immunoglobulin produced from TIB 
in the blood was analyzed by ELISA. A cDNA library was constructed 
from A904L cells and immunoscreening was performed by SEREX 
method by using IgG derived from TIB. 
Results: As a result of the cDNA library screening, 22 different antigen 
genes were isolated. A homology search through BLAST database 
revealed that the 22 antigen genes included 13 function-known and 9 
function-unknown genes. Identiﬁed antigens were sequenced and 4 of 
these antigens had extracellular domain. We designated one of these 
antigens as UOEH-LC-1. The mRNA expression of UOEH-LC-1 was 
investigated in lung cancer cell lines, normal tissues and tissue speci-
mens of lung cancer, using quantitative RT-PCR. UOEH-LC-1 was 
overexpressed in 5 of 11 (45.5%) lung cancer cell lines and also was 
overexpressed in 9 of 15 (60%) lung cancer tissues compared with the 
paired normal lung tissues. mRNA of UOEH-LC-1 was expressed in 
heart, kidney, liver, prostate, testis and thyroid gland among the panel 
of 20 normal tissues. Immunohistochemical evaluation of UOEH-LC-
1 was performed in the lung cancer tissue specimens by using rabbit 
polyclonal Ab against UOEH-LC-1. Seven out of 28 (25.0%) lung 
cancer specimens demonstrated positive staining on the cell surface. 
Flow cytometry analysis using the polyclonal Ab revealed positive 
staining on lung cancer cell lines which were positive expression 
of mRNA of UOEH-LC-1, however negative staining for a cell line 
with negative mRNA expression of UOEH-LC-1. The suppressive 
effect of polyclonal Ab was examined in SCID mice model xenotrans-
planted with UOEH-LC-1 positive lung cancer cell line (A904L). The 
administration of anti-UOEH-LC-1 Ab inhibited the growth of A904L. 
Complement-dependent-cytotoxicity (CDC) of anti-UOEH-LC-1 Ab 
was observed against UOEH-LC-1 positive 2 cell lines, but not against 
a UOEH-LC-1 negative lung cancer cell line. One possible mechanism 
of an anti-tumor effect of anti-UOEH-LC-1 Ab was mediated by the 
CDC activity. 
Conclusions: UOEH-LC-1 was overexpressed on the cell surface of 
lung cancer. Furthermore, the antibody against UOEH-LC-1 had anti-
tumor activity both in vitro and in vivo. The growth inhibitory effects 
of the Ab on lung cancer indicates the usefulness of UOEH-LC-1 as an 
effective target for antibody-based immunotherapy.
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Background: It has been reported that there are several gender-associ-
ated differences in clinicopathological features of non-small cell lung 
cancer (NSCLC). The aim of this study was to measure the relative 
expression levels of estrogen receptor (ER) mRNA in NSCLC tissue, 
and to characterize the role of estrogen in gender differences. 
Methods: The ER mRNA expression levels in 20 parafﬁn-embedded 
samples of surgically resected NSCLC tissue were retrospectively de-
termined by RT-PCR. The ER mRNA expression levels were prospec-
tively measured in snap-frozen materials of both lung cancer tissue and 
normal lung in patients with adenocarcinoma. In both studies, the gene 
expression levels were determined as the relative values to the expres-
sion level of GAPDH. 
Results: In parafﬁn-embedded materials of NSCLC, the ERα mRNA 
expression level was signiﬁcantly higher in females (p=0.0003, versus 
males), non-smokers (p=0.0001, versus former or current-smokers), 
and adenocarcinoma (p=0.003, versus non-adenocarcinoma). The 
ER β mRNA expression level was signiﬁcantly higher in females 
(p=0.02, versus males) and non-smokers (p=0.02, versus former or 
current-smokers). A high expression level of ERα was associated with 
well-differentiated adenocarcinoma of females. In snap-frozen normal 
lung tissues, the ERα mRNA expression levels in males (n=4) and in 
females (n=3) were 9.85±12.80×10-3 and 8.90±5.90×10-3, respectively. 
On the other hand, the ERα mRNA expression levels in adenocarci-
noma tissue had the tendency to be higher in females than in males 
(15.87±22.57×10-3 versus 6.40±11.0×10-3). 
Conclusions: ERs were highly expressed in female pulmonary adeno-
carcinoma tissue. The results suggest that estrogens play a role in the 
development of female pulmonary adenocarcinoma, and are associated 
with the gender-differences in NSCLC. 
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The Fas/FasL system is a primary mediator of apoptosis. It plays an im-
portant role in the development of lung cancer. Osteoprotegerin (OPG) 
blocks endothelial cell apoptosis through binding to TRAIL (TNF 
related apoptosis inducing ligand). Elevated serum levels of soluble Fas 
(sFas), soluble FasL (sFasL) and OPG have been observed in patients 
with many kinds of cancer. The dates about levels of sFas, sFasL and 
OPG in lung cancer are poor. The present study was carried out to ana-
